radicava

Generic: edaravone

Labeler: tanabe pharma america, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name radicava
Generic Name edaravone
Labeler tanabe pharma america, inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

edaravone 30 mg/100mL

Manufacturer
Tanabe Pharma America, Inc.

Identifiers & Regulatory

Product NDC 70510-2171
Product ID 70510-2171_33ff8cc4-15ac-42a1-889e-63fb7493be87
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA209176
Listing Expiration 2026-12-31
Marketing Start 2017-05-05

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705102171
Hyphenated Format 70510-2171

Supplemental Identifiers

RxCUI
1924316 1924317 2602117 2602122
UPC
0370510232414 0370510217121 0370510232315
UNII
S798V6YJRP

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name radicava (source: ndc)
Generic Name edaravone (source: ndc)
Application Number NDA209176 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 30 mg/100mL
source: ndc
Packaging
  • 2 BAG in 1 CARTON (70510-2171-2) / 100 mL in 1 BAG (70510-2171-1)
source: ndc

Packages (1)

Ingredients (1)

edaravone (30 mg/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "33ff8cc4-15ac-42a1-889e-63fb7493be87", "openfda": {"upc": ["0370510232414", "0370510217121", "0370510232315"], "unii": ["S798V6YJRP"], "rxcui": ["1924316", "1924317", "2602117", "2602122"], "spl_set_id": ["0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11"], "manufacturer_name": ["Tanabe Pharma America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BAG in 1 CARTON (70510-2171-2)  / 100 mL in 1 BAG (70510-2171-1)", "package_ndc": "70510-2171-2", "marketing_start_date": "20170505"}], "brand_name": "RADICAVA", "product_id": "70510-2171_33ff8cc4-15ac-42a1-889e-63fb7493be87", "dosage_form": "INJECTION", "product_ndc": "70510-2171", "generic_name": "EDARAVONE", "labeler_name": "Tanabe Pharma America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RADICAVA", "active_ingredients": [{"name": "EDARAVONE", "strength": "30 mg/100mL"}], "application_number": "NDA209176", "marketing_category": "NDA", "marketing_start_date": "20170505", "listing_expiration_date": "20261231"}